Corline Biomedical AB (STO:CLBIO)
Sweden · Delayed Price · Currency is SEK 13.80
-0.40 (-2.82%)
Nov 2, 2026, 2:40 PM CET
Corline Biomedical AB Market Cap
Corline Biomedical AB has a market cap or net worth of 360.64 million as of November 2, 2026. It is the 32,073rd most valuable company in the world and the 432nd biggest in Sweden. Its market cap has decreased by 25.63% in one year.
Market Cap
360.64M
Enterprise Value
332.56M
Revenue
12.39M
Global Rank
Country Rank
#432 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 3, 2015, Corline Biomedical AB's market cap has increased from 97.97M to 360.64M, an increase of 268.13%. That is a compound annual growth rate of 12.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 360.64M | 2.32% |
| Dec 30, 2025 | 352.45M | 86.79% |
| Dec 30, 2024 | 188.69M | -41.07% |
| Dec 29, 2023 | 320.21M | 61.61% |
| Dec 30, 2022 | 198.15M | -36.85% |
| Dec 30, 2021 | 313.77M | 25.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oncopeptides AB | 661.32M |
| Xspray Pharma AB | 559.52M |
| FluoGuide | 498.65M |
| Cantargia AB | 451.68M |
| Isofol Medical AB | 383.95M |
| Sprint Bioscience AB | 379.86M |
| BioInvent International AB | 357.32M |
| Mendus AB | 352.63M |